Cours Northwest Biotherapeutics, Inc Nasdaq
Actions
US66737P6007
Recherche biotechnologique et médicale
CA 2022 | 1,68 M 1,54 M | CA 2023 | 1,93 M 1,77 M | Capitalisation | 822 M 753 M |
---|---|---|---|---|---|
Résultat net 2022 | -105 M -96,22 M | Résultat net 2023 | -62 M -56,81 M | VE / CA 2022 | 505 x |
Dette nette 2022 | 19,29 M 17,67 M | Dette nette 2023 | 43,43 M 39,8 M | VE / CA 2023 | 448 x |
PER 2022 |
-7,59
x | PER 2023 |
-11,7
x | Employés | - |
Rendement 2022 * |
-
| Rendement 2023 |
-
| Flottant | 89,96% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Linda F. Powers
CEO | Chief Executive Officer | 68 | 17/05/07 |
Alton L. Boynton
FOU | Founder | 79 | 18/03/96 |
Marnix L. Bosch
CTO | Chief Tech/Sci/R&D Officer | 65 | 01/01/00 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Alton L. Boynton
FOU | Founder | 79 | 18/03/96 |
Linda F. Powers
CEO | Chief Executive Officer | 68 | 17/05/07 |
Navid Malik
BRD | Director/Board Member | 55 | 01/04/12 |
Varia. 1 janv. | Capi. | |
---|---|---|
-1,17% | 102 Md | |
+2,87% | 96,09 Md | |
+2,13% | 22,28 Md | |
-14,77% | 21,4 Md | |
-8,79% | 18,14 Md | |
-39,98% | 17,02 Md | |
-13,21% | 16,09 Md | |
+8,55% | 13,83 Md | |
+35,75% | 11,97 Md |